Nemiralisib
Nemiralisib Uses, Dosage, Side Effects, Food Interaction and all others data.
Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)).
| Trade Name | Nemiralisib |
| Generic | Nemiralisib |
| Nemiralisib Other Names | Nemiralisib |
| Type | |
| Formula | C26H28N6O |
| Weight | Average: 440.551 Monoisotopic: 440.232459546 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nemiralisib
